NeuroPace Files 8-K: Operations, Personnel, and Financials
Ticker: NPCE · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1528287
| Field | Detail |
|---|---|
| Company | Neuropace Inc (NPCE) |
| Form Type | 8-K |
| Filed Date | Jan 8, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $11.93, $40,000, $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, personnel-changes
TL;DR
NeuroPace dropped an 8-K covering ops, exec changes, and financials. Check it.
AI Summary
NeuroPace Inc. filed an 8-K on January 8, 2025, reporting on events as of January 6, 2025. The filing covers results of operations, financial condition, director and officer changes, and other events. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing provides crucial updates on NeuroPace's operational and financial status, as well as any changes in its leadership, which are important for investors to monitor.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing updates on standard corporate events and financial information.
Key Players & Entities
- NeuroPace Inc. (company) — Registrant
- January 6, 2025 (date) — Date of earliest event reported
- January 8, 2025 (date) — Filing Date
- 455 N. Bernardo Avenue, Mountain View, CA 94043 (location) — Principal executive offices address
FAQ
What specific financial results or conditions are being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
Are there any notable departures or appointments of directors or officers mentioned?
Yes, the filing lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item covered.
What other types of events are reported in this 8-K filing?
The filing also includes 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K form officially filed with the SEC?
The 8-K form was filed on January 8, 2025.
What is NeuroPace Inc.'s principal executive office address?
NeuroPace Inc.'s principal executive offices are located at 455 N. Bernardo Avenue, Mountain View, CA 94043.
Filing Stats: 1,006 words · 4 min read · ~3 pages · Grade level 11.7 · Accepted 2025-01-08 16:38:35
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share NPCE The Nasdaq
- $11.93 — th an exercise price per share equal to $11.93 per share. Subject to Mr. Huennekens' c
- $40,000 — y, which includes an annual retainer of $40,000 for serving on the Board and an additio
- $10,000 — rd and an additional annual retainer of $10,000 for serving as a member of the Audit Co
Filing Documents
- d889166d8k.htm (8-K) — 31KB
- d889166dex991.htm (EX-99.1) — 17KB
- g889166g0108114801664.jpg (GRAPHIC) — 4KB
- 0001193125-25-003547.txt ( ) — 181KB
- npce-20250106.xsd (EX-101.SCH) — 3KB
- npce-20250106_lab.xml (EX-101.LAB) — 18KB
- npce-20250106_pre.xml (EX-101.PRE) — 11KB
- d889166d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated January 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NeuroPace, Inc. Dated: January 8, 2025 By: /s/ Rebecca Kuhn Rebecca Kuhn Chief Financial Officer and Vice President, Finance and Administration